AuroMedics Pharma LLC
NDC labeler code: 55150
What is a labeler?
The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.
Official FDA data only
Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.
Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.
Prescription medicines
- GlycopyrrolateGlyrx-Pf, Glycate, Cuvposa · 4 products
- Amiodarone hydrochloridePacerone, Nexterone · 3 products
- AcyclovirZovirax, Avaclyr · 2 products
- Atracurium besylate2 products
- CyanocobalaminNascobal · 1 product
- Zoledronic acidReclast · 1 product
- Sodium nitroprussideNipride Rtu · 1 product
FDA applications for these products
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Approved | Application | Medicine | Sponsor |
|---|---|---|---|
| December 10, 2020 | ANDA211934 | Sodium nitroprusside SODIUM NITROPRUSSIDE | Eugia Pharma |
| December 8, 2020 | ANDA213874 | Cyanocobalamin CYANOCOBALAMIN | Eugia Pharma |
| November 28, 2018 | ANDA210244 | Glycopyrrolate GLYCOPYRROLATE | Eugia Pharma |
| October 25, 2017 | ANDA204550 | Amiodarone hydrochloride AMIODARONE HYDROCHLORIDE | Eugia Pharma |
| September 26, 2016 | ANDA207751 | Zoledronic acid ZOLEDRONIC ACID | Eugia Pharma |
| April 8, 2015 | ANDA206010 | Atracurium besylate ATRACURIUM BESYLATE PRESERVATIVE FREE | Eugia Pharma |
| April 8, 2015 | ANDA206011 | Atracurium besylate ATRACURIUM BESYLATE | Eugia Pharma |
| October 11, 2013 | ANDA203701 | Acyclovir ACYCLOVIR SODIUM | Eugia Pharma |
The sponsor is the company that holds the FDA application; it can differ from the labeler.
Recall timeline
2026
-
July 15, 2026 · Class III · Ongoing · D-0713-2026 · Lidocaine, Triamcinolone acetonide
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Lidolog Kit, Kit Contains: Lidocaine HCl Injection, USP, 2% (2mL) vial, 1 Dose, Single use Only, Rx Only, Distributed by: Enovachem Pharmaceuticals, Torrance, CA 90501, NDC: 76420-760-01.
-
May 18, 2026 · Class III · Ongoing · D-0552-2026 · Lidocaine, Triamcinolone acetonide
Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan
Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520. NDC: 55150-164-02
2025
-
May 29, 2025 · Class II · Ongoing · D-0472-2025 · Gentamicin sulfate
Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.
Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ, 08520 Vial- NDC 55150-401-01, Carton NDC 55150-401-25
-
April 21, 2025 · Class II · Ongoing · D-0390-2025 · Tirofiban
Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.
Tirofiban Hydrochloride Injection 12.5 mg/250 mL (50 mcg/mL), 250 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-430-01
-
April 21, 2025 · Class II · Ongoing · D-0389-2025 · Tirofiban
Out-of-Specification test results were obtained in at long term conditions during 3 month's stability study for related substances.
Tirofiban Hydrochloride Injection 5 mg/100 mL (50 mcg/mL), 100 mL single-dose container (bag), Rx only, Manufactured in India for: Eugia U.S. LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520, NDC 55150-429-01
-
April 10, 2025 · Class II · Ongoing · D-0363-2025 · Testosterone cypionate
cGMP: complaints of crystals not redissolving into solution after warming and shaking the vials.
Testosterone Cypionate Injection, USP, CIII, 200mg per mL, Rx only, 1mL Single-Dose Vial, Distributed by Eugia US LLC, E. Windsor, NJ, Manufactured by: Eugia Specialties Limited, Telangana State, India, NDC 55150-277-01
2024
-
December 27, 2024 · Class II · Ongoing · D-0186-2025 · Progesterone
Presence of Particulate Matter: A market complaint was received of a glass piece in the vial.
Progesterone Injection USP, 500mg per 10 mL (50mg/mL), 10 mL Multiple Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor NJ 08520 NDC # 55150-306-10
-
December 18, 2024 · Class II · Ongoing · D-0185-2025 · Medroxyprogesterone acetate
CGMP Deviations
medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL, Rx only, 1 mL Single-Dose Vial, Mfd in India for: Eugia US LLC, NJ 08520 NDC 55150-329-01 Shipper label: medroxyPROGESTERone Acetate Injectable Suspen
-
July 26, 2024 · Class II · Ongoing · D-0624-2024 · Progesterone
Presence of Particulate Matter: Complaint received of a glass particle in the vial.
Progesterone Injection, USP, 500 mg per 10 mL (50mg/mL), 10 mL Multiple-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E Windsor, NJ 08520, NDC 55150-306-10.
-
May 23, 2024 · Class II · Ongoing · D-0555-2024 · Dexamethasone
Failed Impurities/Degradation Specifications: impurity sulfonic acid adduct of dexamethasone phosphate results were above spec.
Dexamethasone Sodium Phosphate injection USP, 120mg per 30mL (4mg/mL), 30 mL Multiple-Dose Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520, Made in India, NDC 55150
Show the 40 older recalls
2024
-
May 22, 2024 · Class III · Ongoing · D-0556-2024 · Eptifibatide
Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.
Eptifibatide injection 20mg/10mL (2mg/mL), 10mL Single-Dose Vial, Rx only, Mfd. In India for: AuroMedics Pharma, LLC, E. Windsor, NJ 08520, NDC 55150-219-10
-
February 22, 2024 · Class II · Terminated · D-0385-2024 · Tobramycin
Failed Stability Specification: Water determination was found not complying with specification.
Tobramycin for Injection, USP, 1.2 grams per Pharmacy Bulk Package, Rx Only, For Intravenous Use, PHARMACY BULK PACKAGE NOT FOR DIRECT INFUSION, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, Carton NDC 55150-470
-
February 20, 2024 · Class II · Ongoing · D-0390-2024 · Nicardipine
Failed Impurities/Degradation Specifications: Out of specification for organic impurities
Nicardipine Hydrochloride Injection (2.5mg/mL), US, 25mg per 10mL, 10mL Vial, Rx only, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520 NDC 55150-183-10
-
February 20, 2024 · Class II · Ongoing · D-0391-2024 · Nicardipine
Failed Impurities/Degradation Specifications: Out of specification for organic impurities
Nicardipine Hydrochloride Injection, USP 25mg/mL (2.5 mg/mL) 10 mL vials, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520, NDC 55150-183-11
-
February 20, 2024 · Class II · Ongoing · D-0366-2024 · Methylprednisolone acetate
Failed Dissolution Specifications
Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01
-
February 15, 2024 · Class I · Ongoing · D-0440-2024 · Methocarbamol
Presence of Particulate Matter
Methocarbamol Injection, USP 1000mg/10mL, (100mg/mL), 10 mL Single-Dose Vial packed 25 vials per carton, Rx Only, Mfd. in India for: Eugia US LLC. E. Windsor, NJ 08520, NDC 55150-223-10
-
February 7, 2024 · Class II · Terminated · D-0371-2024 · Rocuronium bromide
cGMP Deviations: Products were stored outside the drug label specifications.
Rocuronium Bromide Injection, Preservative Free, 10 mg / mL, Multiple-Dose Vial 10 mL, Rx only, Mfg: Auromedics Pharma LLC, NDC 55150-226-10
2023
-
September 28, 2023 · Class II · Ongoing · D-0041-2024 · Triamcinolone acetonide
Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial.
Triamcinolone Acetonide Injectable Suspension, USP, 400 mg per 10 mL (40mg/mL), 10 mL Multiple Dose Vial, Rx Only, For Intramuscular or Intra-articular use only, Shake Well, Not for IV/ID, intraocular, epidural, or intra
2022
-
December 28, 2022 · Class II · Ongoing · D-0095-2023 · Acyclovir
Presence of Particulate Matter: Customer complaint of dark particles found inside the vial
Acyclovir Sodium Injection 1,000 mg per 20 mL* (50 mg/mL); Single Dose 20mL Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd, E. Windsor, NJ 08520; Made in India. NDC 55150-155-20
-
September 30, 2022 · Class II · Terminated · D-0020-2023 · Fondaparinux sodium
Subpotent Drug: Out of specification for assay
Fondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Single Dose, Prefilled Syringe, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520. Made in India. NDC 55150-232-10 (carton)NDC
-
September 26, 2022 · Class II · Completed · D-0013-2023 · Acyclovir
Presence of Particulate Matter: Customer complaint for a dark red, brown and black particulate floating inside vial.
Acyclovir Sodium Injection, 500mg/10mL (50mg/mL), 10 mL Single Dose Vial, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ 08520; Made in India, NDC 55150-154-10.
-
September 26, 2022 · Class III · Ongoing · D-1551-2022 · Tranexamic acid
Presence of Particulate Matter: Piece of metal found in a vial
Tranexamic Acid Injection, USP, 1000mg per 10 mL (100mg /mL), 10mL single-dose vial, Rx Only, Distributed by: AuroMedics Pharma LLC E. Windsor, NJ 08520, Made in India, NDC 55150-188-10
-
April 13, 2022 · Class II · Terminated · D-0998-2022 · Bupivacaine hydrochloride
cGMP deviations: Temperature abuse
Bupivacaine HCl Injection, single dose vial, Preservative Free 0.5%, 10mL (25/ct), Rx only, Manufacturer: Auromedics Pharma LLC, NDC 55150-169-10
-
April 13, 2022 · Class II · Terminated · D-1009-2022 · Ampicillin
cGMP deviations: Temperature abuse
Ampicillin for Injection, USP, 1 g per vial, 10-count box, Rx only, Distributed by: Auromedics Pharma, NDC 55150-113-10
-
April 13, 2022 · Class II · Terminated · D-0997-2022 · Azithromycin
cGMP deviations: Temperature abuse
Azithromycin for Injection USP Vial, 500 mg per vial, Rx only, Manufacturer: Auromedics Pharma LLC, NDC 55150-174-10
-
April 5, 2022 · Class III · Terminated · D-0766-2022 · Cyanocobalamin
Subpotent Drug: Out of Specification results for Assay
Cyanocobalamin Injection, USP, 1,000 mcg per mL, For IM or SC Use Only, 1 mL Vial, Rx Only, Manufactured in India, for Auromedics Pharma LLC, NDC 55150-364-01.
-
January 26, 2022 · Class I · Terminated · D-0556-2022 · Polymyxin b sulfate
Presence of Particulate Matter; product complaint of hair discovered in a vial within the lot
Polymyxin B for Injection USP, 500,000 Units per Vial, 10 mL vials, packaged in 10 vials per carton, Sterile, Rx Only, Distributed by: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-234-10
2020
-
December 30, 2020 · Class II · Terminated · D-0248-2021 · Acetaminophen
Discoloration and failed pH specifications
Acetaminophen Injection 1,000 mg per 100 mL (10 mg/mL), 100 mL Single Dose Vial, For Intravenous Use Only, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520 Made in India NDC 55150-3
-
February 7, 2020 · Class III · Terminated · D-0853-2020 · Glycopyrrolate
Failed Impurities/Degradation Specifications: elevated levels of Benzaldehyde impurity was found in investigative samples (retain samples).
Glycopyrrolate Injection, USP 4 mg per 20 mL (0.2 mg/mL), 20 mL Multiple Dose Vial, Rx Only, For Intramuscular or Intravenous Use, Not for Use in Newborns, Contains Benzyl Alcohol, Distributed by: AuroMedics Pharma LLC,
2019
-
November 25, 2019 · Class II · Terminated · D-0574-2020 · Vancomycin
Discoloration: Product complaints of discoloration after reconstitution of vials.
Vancomycin Hydrochloride for Injection, USP, 1 g* per vial, packaged in 10-count vials per carton, Rx only, Mft. in India for: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-204-20.
-
November 11, 2019 · Class III · Terminated · D-0521-2020 · Amiodarone hydrochloride
Crystallization: Presence of visible particulate matter.
Amiodarone Hydrochloride Injection, USP, 450 mg per 9 mL (50 mg / mL), 9 mL Single Dose Vial, Rx only, Distributed by AuroMedics Pharma LLC E. Windsor, NJ. 08520, Made in India. NDC 55150-181-09
-
November 11, 2019 · Class III · Terminated · D-0520-2020 · Amiodarone hydrochloride
Crystallization: Presence of visible particulate matter.
Amiodarone Hydrochloride Injection, USP, 150 mg per 3 mL (50 mg / mL), 3 mL Single Dose Vial, Rx only, Distributed by AuroMedics Pharma LLC E. Windsor, NJ. 08520, Made in India. NDC 55150-180-03
-
November 11, 2019 · Class III · Terminated · D-0522-2020 · Amiodarone hydrochloride
Crystallization: Presence of visible particulate matter.
Amiodarone Hydrochloride Injection, USP, 900 mg per 18 mL (50 mg / mL), 18 mL Multiple Dose Vial, Rx only, Distributed by AuroMedics Pharma LLC E. Windsor, NJ. 08520, Made in India. NDC 55150-182-18
-
November 11, 2019 · Class II · Terminated · D-0573-2020 · Bupivacaine hydrochloride, Lidocaine
Presence of Foreign Substance: Foreign material found inside the vial.
Lidocaine HCl Injection, USP, 2% 100 mg/5 mL (20 mg/mL), Preservative-Free, packaged in 10 x 5 mL Single Dose Vials per carton, Rx only, Distributed by: AuroMedics Pharma LLC, 279 Princeton-Hightstown Rd., E. Windsor, NJ
-
March 28, 2019 · Class I · Terminated · D-1248-2019 · Betamethasone sodium phosphate and betamethasone acetate, Bupivacaine hydrochloride, Lidocaine
Presence of Particulate Matter: One vial was found to contain a hair.
Lidocaine HCl Injection, USP 1 % 50 mg/5 mL (10 mg/mL), 5mL vial, Rx only, Mrd. in India for: AuroMedics Pharna LLC. E Windsor, NJ 08520 NDC 55150-162-05
2018
-
July 2, 2018 · Class I · Terminated · D-1030-2018 · Piperacillin and tazobactam
Presence of Particulate Matter: identified as glass and silicone material
Piperacillin and Tazobactam for Injection USP 3.375 grams per vial, Single-Dose Vial, Rx Only. Manufactured for: Auromedics Pharma LLC 6 Wheeling Road Dayton NJ 08810, Made in India. NDC 55150-120-30
-
May 1, 2018 · Class I · Terminated · D-0926-2018 · Piperacillin and tazobactam
Presence of Particulate Matter: confirmed customer report for presence of visible particulate matter, confirmed as glass
Piperacillin and Tazobactam for Injection, USP 3.375 grams per vial, For Intravenous Use Only, Single-Dose vial, Rx Only, Manufactured for: AuroMedics Pharma LLC, 6 Wheeling Road, Dayton, NJ 05610. NDC 55150-120-30
-
May 1, 2018 · Class I · Terminated · D-0866-2018 · Ampicillin sodium and sulbactam sodium
Presence of Particulate Matter: confirmed customer report of the presence of visible particulate matter believed to be red rubber particles from the manufacturing process of the active ingredients.
Ampicillin and Sulbactam for Injection, USP, 3 gram*s/vial, For Intramuscular or Intravenous Use, Sterile, Manufactured for: AuroMedics Pharma LLC, 6 Wheeling Road, Dayton, NJ, NDC 55150-117-20.
-
March 27, 2018 · Class II · Terminated · D-0706-2018 · Levetiracetam
Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap
Levetiracetam in 0.75% Sodium Chloride Injection, 1000 mg per 100 mL (10 mg/mL), For Intravenous Infusion Only, Distributed By: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-247-47.
-
March 27, 2018 · Class II · Terminated · D-0705-2018 · Levetiracetam
Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap
Levetiracetam in 0.82% Sodium Chloride Injection, 500 mg per 100 mL (5 mg/mL), For Intravenous Infusion Only, Distributed By: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-246-47.
-
March 27, 2018 · Class II · Terminated · D-0707-2018 · Levetiracetam
Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap
Levetiracetam in 0.54% Sodium Chloride Injection, 1,500 mg per 100 mL (15 mg/mL), For Intravenous Infusion Only, Distributed By: AuroMedics Pharma LLC, E. Windsor, NJ 08520, NDC 55150-248-47.
-
March 27, 2018 · Class II · Terminated · D-0709-2018 · Levofloxacin
Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap
Levofloxacin in 5% Dextrose Injection, 750 mg Levofloxacin (5 mg/mL) in 150 mL of 5% Dextrose, For Intravenous Infusion, Rx only, Manufactured By: Aurobindo Pharma Limited IDA Pashamylaram - 502307, India, Manufactured f
-
March 27, 2018 · Class II · Terminated · D-0708-2018 · Levofloxacin
Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap
Levofloxacin in 5% Dextrose Injection, 500 mg Levofloxacin (5 mg/mL) in 100 mL of 5% Dextrose, For Intravenous Infusion, Rx only, Manufactured By: Aurobindo Pharma Limited IDA Pashamylaram - 502307, India, Manufactured f
-
March 27, 2018 · Class II · Terminated · D-0704-2018 · Levofloxacin
Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap
Levofloxacin in 5% Dextrose Injection, 250 mg Levofloxacin (5 mg/mL) in 50 mL of 5% Dextrose, For Intravenous Infusion, Rx only, Manufactured By: Aurobindo Pharma Limited IDA Pashamylaram - 502307, India, Manufactured fo
-
March 27, 2018 · Class II · Terminated · D-0703-2018 · Linezolid
Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap
Linezolid Injection 600 mg per 300 mL (2 mg/mL) For Intravenous Administration, Rx only, Manufactured By: Aurobindo Pharma Limited IDA Pashamylaram - 502307, India, Manufactured for AuroMedics Pharma, LLC, NDC 55150-242-
-
January 12, 2018 · Class I · Terminated · D-0574-2018 · Levofloxacin
Presence of Particulate Matter; contains visible particulate matter identified as mold.
Levofloxacin in 5% Dextrose Injection, 250 mg/50 mL (5 mg/mL), 50 mL Single-Use flexible container, Rx Only, Manufactured for: AuroMedics Pharma LLC 6 Wheeling Drive, Dayton, NJ 08810 Manufactured for: Aurobindo Pharma L
-
January 2, 2018 · Class I · Terminated · D-0339-2018 · Ampicillin sodium and sulbactam sodium
Presence of Particulate Matter: A confirmed customer report was received for the presence of visible particulate matter, confirmed as glass, within a single vial.
Ampicillin and Sulbactam for Injection 1.5 g vial, sterile Dry Powder for injection, 10 vials per carton, Distributed by AuroMedics Pharma LLC. 279 Princeton-Highstown Rd. E. Windsor, NJ 08520, NDC 55150-116-20
2017
-
December 20, 2017 · Class I · Terminated · D-0337-2018 · Linezolid
Presence of Particulate Matter; white particulate matter identified as mold was found in one bag
Linezolid Injection 600 mg/300 mL (2 mg/mL), 300 mL Single-use, ready-to-use flexible plastic infusion bags in a foil laminate overwrap, Rx only, Mfd in India for: AuroMedics Pharma LLC, Dayton, NJ --- NDC 55150-242-51
-
December 4, 2017 · Class I · Terminated · D-0340-2018 · Pantoprazole sodium
Presence of Particulate Matter: One vial from a lot of Pantoprazole Sodium for Injection (40 mg) contained a piece of glass
Pantoprazole Sodium for Injection, 40 mg per vial, single dose vial, Rx only, Manufactured in India for: AuroMedics Pharma LLC, 6 Wheeling ROad, Dayton, NJ 08810. NDC 55150-202-00
2016
-
December 16, 2016 · Class III · Terminated · D-0470-2017 · Pantoprazole sodium
Discoloration: Some vials were found to contain powder with a yellowish-brownish appearance.
Pantoprazole Sodium for Injection, 40mg per vial, Single-dose vial, Rx only, Mfd. in India for: Auromedics Pharma LLC 6 Wheeling Road, Dayton, NJ 08810, NDC 55150-202-00
What do the recall classes mean?
Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).
Next steps
- Find a pharmacy near youAsk which company made your medicine and whether it is recalled
- Latest FDA drug recallsAll companies, newest first
- All drug companiesA to Z
- All prescription drugs A to ZSearch by generic, brand or Spanish name
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026